Ceftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamase
Authors:
- 1 November 1990
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 34 (11) , 2070-2074
Abstract
We studied the activity of the combination of sulbactam and ceftriaxone against a Klebsiella pneumoniae strain producing TEM-3, a new extended-broad-spectrum beta-lactamase, in an endocarditis model. In vitro, ceftriaxone was strongly inactivated in the presence of TEM-3 (MBC, 128 micrograms/ml with an inoculum of 5 x 10(5) CFU/ml). A marked inoculum effect was demonstrated with sulbactam: effective concentrations of inhibitor needed to reduce the MIC and MBC of ceftriaxone to similar levels increased from 1 microgram/ml in the presence of an inoculum of 5 x 10(5) CFU/ml to 20 micrograms/ml in the presence of an inoculum of 1 x 10(7) CFU/ml. In vivo, sulbactam given at 200 mg/kg of body weight every 12 h, a dosage higher than that previously reported to be effective against rabbit endocarditis caused by other microorganisms, was not sufficient to restore the complete activity of ceftriaxone given at 30 mg/kg once daily for 4 days. This insufficient activity may be correlated with the presence of a high level of beta-lactamase inside the vegetations, as indicated by a quantitative in vitro assay of beta-lactamase activity in the cardiac vegetation, suggesting an insufficient inactivation of the extended-broad-spectrum beta-lactamase in vivo.Keywords
This publication has 24 references indexed in Scilit:
- Evaluation of Antibiotic Diffusion into Cardiac Vegetations by Quantitative AutoradiographyThe Journal of Infectious Diseases, 1989
- Amino Acid Sequence, Active-Site Residue, and Effect of Suicide Inhibitors on Cephalosporinase of Citrobacter freundii GN346Clinical Infectious Diseases, 1988
- Efficacy of pefloxacin-fosfomycin in experimental endocarditis caused by methicillin-resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1988
- Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel β-lactamaseJournal of Antimicrobial Chemotherapy, 1987
- TRANSFERABLE ENZYMATIC RESISTANCE TO THIRD-GENERATION CEPHALOSPORINS DURING NOSOCOMIAL OUTBREAK OF MULTIRESISTANT KLEBSIELLA PNEUMONIAEThe Lancet, 1987
- Sulbactam/Ampicillin: In Vitro Spectrum, Potency, and Activity in Models of Acute InfectionClinical Infectious Diseases, 1986
- Kinetics and bactericidal effect of gentamicin and latamoxef (moxalactam) in experimental Escherichia coli endocarditisJournal of Antimicrobial Chemotherapy, 1986
- Comparing the Means of Several GroupsNew England Journal of Medicine, 1985
- Pharmacokinetics of sultamicillin in mice, rats, and dogsAntimicrobial Agents and Chemotherapy, 1984
- Pharmacokinetics and bioavailability of sultamicillin estimated by high performance liquid chromatographyJournal of Antimicrobial Chemotherapy, 1983